Evidence-based  ||| S:0 E:15 ||| NNP
and  ||| S:15 E:19 ||| CC
promising  ||| S:19 E:29 ||| JJ
interventions  ||| S:29 E:43 ||| NNS
to  ||| S:43 E:46 ||| TO
prevent  ||| S:46 E:54 ||| VB
drug  ||| S:54 E:59 ||| NN
use  ||| S:59 E:63 ||| NN
among  ||| S:63 E:69 ||| IN
youth ||| S:69 E:74 ||| NN
:  ||| S:74 E:76 ||| :
a  ||| S:76 E:78 ||| DT
literature  ||| S:78 E:89 ||| NN
review  ||| S:89 E:96 ||| NN
France  ||| S:96 E:103 ||| NNP
has  ||| S:103 E:107 ||| VBZ
one  ||| S:107 E:111 ||| CD
of  ||| S:111 E:114 ||| IN
the  ||| S:114 E:118 ||| DT
highest  ||| S:118 E:126 ||| JJS
rates  ||| S:126 E:132 ||| NNS
of  ||| S:132 E:135 ||| IN
psychoactive  ||| S:135 E:148 ||| JJ
substance  ||| S:148 E:158 ||| NN
use  ||| S:158 E:162 ||| NN
among  ||| S:162 E:168 ||| IN
young  ||| S:168 E:174 ||| JJ
people  ||| S:174 E:181 ||| NNS
in  ||| S:181 E:184 ||| IN
Europe ||| S:184 E:190 ||| NNP
.  ||| S:190 E:192 ||| .
Psychoactive  ||| S:192 E:205 ||| JJ
substances  ||| S:205 E:216 ||| NNS
affect  ||| S:216 E:223 ||| VBP
brain  ||| S:223 E:229 ||| NN
functioning  ||| S:229 E:241 ||| NN
and  ||| S:241 E:245 ||| CC
can  ||| S:245 E:249 ||| MD
cause  ||| S:249 E:255 ||| VB
serious  ||| S:255 E:263 ||| JJ
health  ||| S:263 E:270 ||| NN
problems ||| S:270 E:278 ||| NNS
.  ||| S:278 E:280 ||| .
The  ||| S:280 E:284 ||| DT
identification  ||| S:284 E:299 ||| NN
of  ||| S:299 E:302 ||| IN
effective  ||| S:302 E:312 ||| JJ
strategies  ||| S:312 E:323 ||| NNS
and  ||| S:323 E:327 ||| CC
prevention  ||| S:327 E:338 ||| NN
programs  ||| S:338 E:347 ||| NNS
is  ||| S:347 E:350 ||| VBZ
a  ||| S:350 E:352 ||| DT
major  ||| S:352 E:358 ||| JJ
challenge  ||| S:358 E:368 ||| NN
for  ||| S:368 E:372 ||| IN
public  ||| S:372 E:379 ||| JJ
health ||| S:379 E:385 ||| NN
.  ||| S:385 E:387 ||| .
The  ||| S:387 E:391 ||| DT
purpose  ||| S:391 E:399 ||| NN
of  ||| S:399 E:402 ||| IN
this  ||| S:402 E:407 ||| DT
study  ||| S:407 E:413 ||| NN
was  ||| S:413 E:417 ||| VBD
to  ||| S:417 E:420 ||| TO
identify  ||| S:420 E:429 ||| VB
empirically  ||| S:429 E:441 ||| JJ
validated  ||| S:441 E:451 ||| NN
and  ||| S:451 E:455 ||| CC
promising  ||| S:455 E:465 ||| JJ
intervention  ||| S:465 E:478 ||| NN
programs  ||| S:478 E:487 ||| NNS
aimed  ||| S:487 E:493 ||| VBN
at  ||| S:493 E:496 ||| IN
preventing  ||| S:496 E:507 ||| VBG
drug  ||| S:507 E:512 ||| NN
use ||| S:512 E:515 ||| NN
.  ||| S:515 E:517 ||| .
The  ||| S:517 E:521 ||| DT
study  ||| S:521 E:527 ||| NN
used  ||| S:527 E:532 ||| VBD
a  ||| S:532 E:534 ||| DT
standard  ||| S:534 E:543 ||| JJ
protocol  ||| S:543 E:552 ||| NN
to  ||| S:552 E:555 ||| TO
identify  ||| S:555 E:564 ||| VB
and  ||| S:564 E:568 ||| CC
review  ||| S:568 E:575 ||| VB
the  ||| S:575 E:579 ||| DT
literature  ||| S:579 E:590 ||| NN
and  ||| S:590 E:594 ||| CC
to  ||| S:594 E:597 ||| TO
classify  ||| S:597 E:606 ||| VB
the  ||| S:606 E:610 ||| DT
selected  ||| S:610 E:619 ||| JJ
interventions ||| S:619 E:632 ||| NNS
.  ||| S:632 E:634 ||| .
Two  ||| S:634 E:638 ||| CD
criteria  ||| S:638 E:647 ||| NNS
were  ||| S:647 E:652 ||| VBD
used  ||| S:652 E:657 ||| VBN
to  ||| S:657 E:660 ||| TO
classify  ||| S:660 E:669 ||| VB
the  ||| S:669 E:673 ||| DT
results ||| S:673 E:680 ||| NNS
:  ||| S:680 E:682 ||| :
age  ||| S:682 E:686 ||| NN
( ||| S:686 E:687 ||| -LRB-
interventions  ||| S:687 E:701 ||| VB
aimed  ||| S:701 E:707 ||| VBN
at  ||| S:707 E:710 ||| IN
children  ||| S:710 E:719 ||| NNS
under  ||| S:719 E:725 ||| IN
10  ||| S:725 E:728 ||| CD
years  ||| S:728 E:734 ||| NNS
of  ||| S:734 E:737 ||| IN
age  ||| S:737 E:741 ||| NN
versus  ||| S:741 E:748 ||| IN
interventions  ||| S:748 E:762 ||| NNS
aimed  ||| S:762 E:768 ||| VBN
at  ||| S:768 E:771 ||| IN
children  ||| S:771 E:780 ||| NNS
over  ||| S:780 E:785 ||| IN
10  ||| S:785 E:788 ||| CD
years  ||| S:788 E:794 ||| NNS
of  ||| S:794 E:797 ||| IN
age ||| S:797 E:800 ||| NN
)  ||| S:800 E:802 ||| -RRB-
and  ||| S:802 E:806 ||| CC
the  ||| S:806 E:810 ||| DT
type  ||| S:810 E:815 ||| NN
of  ||| S:815 E:818 ||| IN
approach  ||| S:818 E:827 ||| NN
used  ||| S:827 E:832 ||| VBN
in  ||| S:832 E:835 ||| IN
the  ||| S:835 E:839 ||| DT
interventions  ||| S:839 E:853 ||| NNS
( ||| S:853 E:854 ||| -LRB-
universal  ||| S:854 E:864 ||| FW
versus  ||| S:864 E:871 ||| FW
targeted ||| S:871 E:879 ||| FW
) ||| S:879 E:880 ||| -RRB-
.  ||| S:880 E:882 ||| .
Our  ||| S:882 E:886 ||| PRP$
data  ||| S:886 E:891 ||| NNS
suggest  ||| S:891 E:899 ||| VBP
that  ||| S:899 E:904 ||| IN
the  ||| S:904 E:908 ||| DT
most  ||| S:908 E:913 ||| RBS
effective  ||| S:913 E:923 ||| JJ
interventions  ||| S:923 E:937 ||| NNS
generally  ||| S:937 E:947 ||| RB
involve  ||| S:947 E:955 ||| VB
interactive  ||| S:955 E:967 ||| JJ
programs  ||| S:967 E:976 ||| NNS
aimed  ||| S:976 E:982 ||| VBN
at  ||| S:982 E:985 ||| IN
promoting  ||| S:985 E:995 ||| VBG
the  ||| S:995 E:999 ||| DT
development  ||| S:999 E:1011 ||| NN
of  ||| S:1011 E:1014 ||| IN
psychosocial  ||| S:1014 E:1027 ||| JJ
skills  ||| S:1027 E:1034 ||| NNS
in  ||| S:1034 E:1037 ||| IN
children  ||| S:1037 E:1046 ||| NNS
and  ||| S:1046 E:1050 ||| CC
parents ||| S:1050 E:1057 ||| NNS
.  ||| S:1057 E:1059 ||| .
Interventions  ||| S:1059 E:1073 ||| NNS
targeting  ||| S:1073 E:1083 ||| VBG
populations  ||| S:1083 E:1095 ||| NNS
at  ||| S:1095 E:1098 ||| IN
risk  ||| S:1098 E:1103 ||| NN
for  ||| S:1103 E:1107 ||| IN
drug  ||| S:1107 E:1112 ||| NN
use  ||| S:1112 E:1116 ||| NN
require  ||| S:1116 E:1124 ||| VBP
more  ||| S:1124 E:1129 ||| JJR
resources ||| S:1129 E:1138 ||| NNS
,  ||| S:1138 E:1140 ||| ,
including  ||| S:1140 E:1150 ||| VBG
a  ||| S:1150 E:1152 ||| DT
community  ||| S:1152 E:1162 ||| NN
component  ||| S:1162 E:1172 ||| NN
( ||| S:1172 E:1173 ||| -LRB-
based  ||| S:1173 E:1179 ||| VBN
on  ||| S:1179 E:1182 ||| IN
an  ||| S:1182 E:1185 ||| DT
approach  ||| S:1185 E:1194 ||| NN
aimed  ||| S:1194 E:1200 ||| VBN
at  ||| S:1200 E:1203 ||| IN
incorporating  ||| S:1203 E:1217 ||| VBG
a  ||| S:1217 E:1219 ||| DT
range  ||| S:1219 E:1225 ||| NN
of  ||| S:1225 E:1228 ||| IN
local  ||| S:1228 E:1234 ||| JJ
actors ||| S:1234 E:1240 ||| NNS
) ||| S:1240 E:1241 ||| -RRB-
,  ||| S:1241 E:1243 ||| ,
personalized  ||| S:1243 E:1256 ||| JJ
assistance  ||| S:1256 E:1267 ||| NN
( ||| S:1267 E:1268 ||| -LRB-
for  ||| S:1268 E:1272 ||| IN
young  ||| S:1272 E:1278 ||| JJ
people  ||| S:1278 E:1285 ||| NNS
and  ||| S:1285 E:1289 ||| CC
families ||| S:1289 E:1297 ||| NNS
)  ||| S:1297 E:1299 ||| -RRB-
and ||| S:1299 E:1302 ||| CC
,  ||| S:1302 E:1304 ||| ,
in  ||| S:1304 E:1307 ||| IN
many  ||| S:1307 E:1312 ||| JJ
cases ||| S:1312 E:1317 ||| NNS
,  ||| S:1317 E:1319 ||| ,
the  ||| S:1319 E:1323 ||| DT
provision  ||| S:1323 E:1333 ||| NN
of  ||| S:1333 E:1336 ||| IN
psychotherapeutic  ||| S:1336 E:1354 ||| JJ
services ||| S:1354 E:1362 ||| NNS
.  ||| S:1362 E:1364 ||| .
Most  ||| S:1364 E:1369 ||| JJS
of  ||| S:1369 E:1372 ||| IN
the  ||| S:1372 E:1376 ||| DT
interventions  ||| S:1376 E:1390 ||| NN
presented  ||| S:1390 E:1400 ||| VBN
in  ||| S:1400 E:1403 ||| IN
this  ||| S:1403 E:1408 ||| DT
paper  ||| S:1408 E:1414 ||| NN
were  ||| S:1414 E:1419 ||| VBD
implemented  ||| S:1419 E:1431 ||| VBN
in  ||| S:1431 E:1434 ||| IN
English-speaking  ||| S:1434 E:1451 ||| JJ
countries ||| S:1451 E:1460 ||| NNS
.  ||| S:1460 E:1462 ||| .
However ||| S:1462 E:1469 ||| RB
,  ||| S:1469 E:1471 ||| ,
we  ||| S:1471 E:1474 ||| PRP
argue  ||| S:1474 E:1480 ||| VBP
that  ||| S:1480 E:1485 ||| IN
they  ||| S:1485 E:1490 ||| PRP
can  ||| S:1490 E:1494 ||| MD
also  ||| S:1494 E:1499 ||| RB
contribute  ||| S:1499 E:1510 ||| VB
to  ||| S:1510 E:1513 ||| TO
promoting  ||| S:1513 E:1523 ||| VBG
reflection  ||| S:1523 E:1534 ||| NN
and  ||| S:1534 E:1538 ||| CC
improving  ||| S:1538 E:1548 ||| VBG
prevention  ||| S:1548 E:1559 ||| NN
programs  ||| S:1559 E:1568 ||| NNS
in  ||| S:1568 E:1571 ||| IN
France ||| S:1571 E:1577 ||| NNP
.  ||| S:1577 E:1579 ||| .
